|
Regulatory
A Milestone Year for New Drugs, Faster Approvals
FDA set several milestones in approving more than 40 important new drugs and biologics in 2014. FDA commissioner Margaret Hamburg reported in early December that approvals were up to 35 new molecular entities (NMEs), an increase from 27 in 2013; the total reached 41 new drugs by year-end. Jill Wechsler reports ...Read more
New
 research
shows companies spending $400 million on point of care marketing. As changes in the health care market continue, marketing in care venues will become a more important part of companies’ integrated marketing strategies. Read the research to learn how to optimize your investment in point of care marketing.
Opinion
Enhancing the Industry's Reputation: A Four-Point Solution
Following Pharm Exec’s recent profile of Dr. Steve Miller, here the Express Scripts CEO adds some further thoughts — on health reform, cost-effectiveness research, pharma’s reputation, and the obligations of government — to his critique of industry pricing practises ...Read more
Applied Clinical Trials/Pharmaceutical Executive E-Book & Web Portal: Clinical Trial Data Sharing and Disclosure
This e-book features information from a recent conference of global thought-leaders in clinical data disclosure and transparency, which address current practices, potential challenges and solutions for pharmaceutical companies complying with the regulatory, ethical and legal issues around clinical trial data sharing.
Click
 here to download the e-book. Click here to visit the web portal
Global
Cuba: An Untapped Market?
If you’re like us at PharmExec, you’ve been reading the news of potentially thawing US/Cuban relations, and you’re wondering, how long before the flag of Cuba graces the Hall of nations at BIO International Convention? ...Read more
Strategy
AmerisourceBergen: A Burgeoning Giant Steps Out
A subtle and unmistakable shift is now underway among Big Pharma’s network of providers, payers, distributors and service vendors, and is best summarized as “follow the customer.” One strong example of the trend is the $100 billion sourcing and distribution behemoth AmerisourceBergen [ABC], which is building on its success in the US market to expand internationally through a series of strategic ties with foreign enterprise partners. William Looney reports
...Read more
|
